MedPath

SANDOZ LEVETIRACETAM

SANDOZ LEVETIRACETAM

Approved
DIN Number

02461986

Drug Class

Human

Market Date

Aug 4, 2017

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02461986
AIG Number0148843001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX14 LEVETIRACETAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEVETIRACETAMActive
Strength: 250 MG
Monograph: LEVETIRACETAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.